The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (δR2*) and contrast agent (MION) dose

Journal of Magnetic Resonance Imaging

Volumn 18, Issue 4, 2003, Pages 397-403

  Pathak, Arvind P ^a,b,c   Rand, Scott D ^b   Schmainda, Kathleen M ^b  

^a Medical College of Wisconsin and Marquette University   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calibration factor; Gradient echo; Relative cerebral blood volume (rCBV); Susceptibility contrast; Tumor angiogenesis

Indexed keywords

CONTRAST MEDIUM; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD VOLUME; BRAIN TUMOR; CALIBRATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLOW KINETICS; GRAY MATTER; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; RELAXATION TIME; WHITE MATTER;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CALIBRATION; CONTRAST MEDIA; FERROSOFERRIC OXIDE; IRON; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; OXIDES; RATS;

EID: 0141730442     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10371     Document Type: Article

References (25)

1. Belliveau JW, Rosen, BR, Kantor HL, et al. Functional cerebral imaging by susceptibility-contrast NMR. Mag Reson Imaging 1990;14:538-546.
2. Rosen BR, Belliveau JW, Buchbinder BR, et al. Contrast agents and cerebral hemodynamics. Mag Reson Med 1991;19:285-292.
3. Aronen HJ, Cohen MS, Belliveau JW, Fordham JA, Rosen BR. Ultrafast imaging of brain tumors. Top Magn Reson Imaging 1993;5:14-24.
4. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMRimaging of changes in vascular morphology due to tumor angiogenesis. Mag Reson Med 1998;40:793-799.
5. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histological findings. Radiology 1994;191:41-51.
6. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233-238.
7. Donahue KM, Krouwer HGJ, Rand SD, et al. Utility of simultaneously-acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Mag Reson Med 2000;43:845-853.
8. Rosen BR. Perfusion imaging with NMR contrast agents. Mag Reson Med 1990;14:249-265.
9. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Mag Reson Med 1995;34:555-566.
10. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Mag Reson Med 1988;6:164-174.
11. Perman WH, Gado M, Larson KB, et al. The in vivo relationship between Gd-DTPA concentration and ΔR2 for brain parenchyma and arterial blood. 1st Annual Meeting, Society of Magnetic Resonance in Medicine, New York, 1993. p. 388.
12. Jung CW, Weissleder R, Josephson L, Bengele H, Brady TJ. Physical properties of MION-46 and AMI-227. In: Proceedings of the 4th Annual Meeting of ISMRM, New York, 1996. p. 1681.
13. Shen T, Weissleder R, Papisov M, Bogdanov A, Brady TJ. Monocrystalline iron oxide nanoparticles (MION): physiochemical properties. Mag Reson Med 1993;29:599-604.
14. Pathak AP, Schmainda KM, Ward BD, Linderman JR, Rebro KJ, Greene AS. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Mag Reson Med 2001;46:735-747.
15. Rieder MJ, O'Drobinak DM, Greene AS. A computerized method for determination of microvascular density. Microvasc Res 1995;49:180-189.
16. van Bruggen N, Busch E, Palmer JT, Williams S-P. de Crespigny AJ. High-resolution functional magnetic resonance imaging of the rat brain: mapping changes in cerebral blood volume using iron oxide contrast media. J Cereb Blood Flow Metab 1998;18:1178-1183.
17. Boxerman JL, Weisskoff R, Hoppel BE, et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: cylindrical geometry. 1st Annual Meeting. Society of Magnetic Resonance in Medicine, New York, 1993, p. 389.
18. Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Mag Reson Med 2001;46:1113-1122.
19. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988;48:2641-2658.
20. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000;6:351-355.
21. Henry RG, Vigneron D, Fischbein NJ, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 2000;21:357-366.
22. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21:901-909.
23. Uematsu H, Maeda M, Sadato N, et al. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol 2001;22:1915-1919.
24. Li L. Magnetic susceptibility quantification for arbitrarily shaped objects in inhomogeneous fields. Magn Reson Med 2001;46:907-916.
25. Pathak AP, Ward BD, Hudetz AG, et al. A novel technique for estimating the susceptibility-induced MR signal for arbitrary microvascular geometries: the finite perturber method. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, 2002. p. 1331.